Status:

COMPLETED

Dexmedetomidine Added to Bupivacaine Versus Bupivacaine inTransincisionalU/S Guided Quadratus Lumborum Block in Open Renal Surgeries , A New Technique

Lead Sponsor:

Ain Shams University

Conditions:

Anesthesia

Eligibility:

All Genders

20-65 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare the addition of dexmedetomidine to bupivacaine versus bupivacaine only in anterior QLblock(transincisional) , where the local anesthetic will be applied before ...

Eligibility Criteria

Inclusion

  • physical status American Society of Anesthesiologist (ASA) I or II

Exclusion

  • Patients refusal
  • A body mass index (BMI) \>30 kg/m2
  • ASA physical status \>II
  • major illnesses (e.g., cardiac, respiratory, renal, hepatic or neurological)
  • Coagulation abnormalities
  • Infection at the injection site
  • Allergy or contraindications to the drugs used in the study
  • History of drug addiction or alcohol abuse
  • A psychiatric illness, or mental retardation interfering with the evaluation of pain scores or PCA programs .

Key Trial Info

Start Date :

March 6 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 15 2019

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT03869047

Start Date

March 6 2019

End Date

August 15 2019

Last Update

May 19 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University hospitals

Cairo, Egypt

Dexmedetomidine Added to Bupivacaine Versus Bupivacaine inTransincisionalU/S Guided Quadratus Lumborum Block in Open Renal Surgeries , A New Technique | DecenTrialz